
|Podcasts|September 3, 2021
- October 2021
- Volume 15
- Issue 5
Navigating Medical Cannabis in Cancer Care
Author(s)Lindsay Fischer
Over half of the states in the United States have legalized medical cannabis. What does that mean for nurses who care for patients with cancer?
Advertisement
For this episode, we spoke with Eloise Theisen, RN, MSN, AGPCNP-BC, current president of the American Cannabis Nurses Association (ACNA). She spoke to us about some the benefits and applications of medical cannabis for patients with cancer, some of the challenges and interesting updates in medical cannabis research, and how nurses can talk to their patients about cannabis, as well as monitor their patients for potential cannabis-related adverse events.
Articles in this issue
almost 5 years ago
Applying Positive Psychology to Financial Planningalmost 5 years ago
Continuing Education: October 2021almost 5 years ago
Should the Oncology Nurse Get Vaccinated?almost 5 years ago
Health Literacy Is Positively Associated With Medication Adherencealmost 5 years ago
Fall Into Better Health and Financial Practicesabout 5 years ago
Nurses Can Minimize Fear, Anxiety in Pediatric Patients With CancerAdvertisement
Related to this article


Beth Faiman, PhD, and Sikander Ailawadhi, MD, discuss clinic workflows, safety checks, and at-home dosing potential for on-body isatuximab.

Beth Faiman, PhD, and Sikander Ailawadhi, MD, discuss clinical trials and nursing impacts of on-body isatuximab delivery in multiple myeloma.

In a randomized trial, 73% of relatives offered navigation completed genetic testing within 6 months vs 51% of those who received a family letter.

In observation of National PA Week, Moffitt PA Mark Honor details top-of-license nursing collaboration and outpatient end-stage hematology care.

Adding atezolizumab to adjuvant FOLFOX halved the risk of recurrence or death in ATOMIC, with more grade 3 to 4 adverse events.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Navigation Boosts Cascade Genetic Testing in Relatives of BRCA Carriers
2
FDA Approves Atezolizumab Plus Chemo for Stage 3 dMMR Colon Cancer
3
Daily Symptom Shifts Linked to Quality of Life in Metastatic Breast Cancer
4
Multidisciplinary Support for Patients with Metastatic Triple-Negative Breast Cancer
5

